immunitoAI, a Bangalore, India-based biotech startup that developed an AI-powered antibody discovery and screening platform, raised $1 million in Seed funding.
The round was led by Pi Ventures, with existing investor Entrepreneur First.
immunitoAI plans to use this funding to develop AI products and validate the predictions through biological experiments.
Company: immunitoAI Private Limited
Raised: $1.0M
Round: Seed Round
Funding Month: September 2021
Lead Investors: Pi Ventures
Additional Investors: Entrepreneur First
Company Website: https://www.immunitoai.com/
Software Category: Biotech platform > AI
About the Company: Founded in November 2020 by Aridni Shah and Trisha Chatterjee, immunitoAI designs and screens antibody candidates for a given antigen. With this technology, the startup aims to increase the number of antibodies discovered drastically, making targeted therapy a norm in the future. ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery & therapeutics.
Source: https://yourstory.com/2021/09/biotech-startup-immunitoai-raises-seed-round-piventures/amp